Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06475950

Impact of the "Kid'EM App" Digital Guidance Tool for Setting Rehabilitation Goals by the Rehabilitation Professional for Children with Chronic Conditions Impacting Physical Health (READ'APP'T)

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
252 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

On an individual level, the first expected benefit for the child using the "Kid'EM app" would be an improvement in the quality of his or her rehabilitation goals, which would be more Specific, Measurable, Activity-related, Realistic and Time-defined (SMART). A second expected benefit for the child, thanks to the work carried out in rehabilitation sessions on objectives adapted to his or her needs and day-to-day life, encouraging commitment and motivation, would be to improve the effectiveness of the care offered to him or her, thereby enhancing autonomy and physical health. For parents, taking part in goal-setting, by contributing their knowledge of their child and his or her daily life, would increase their involvement in their child's care and improve their satisfaction with the care offered. By setting SMART functional goals and facilitating communication between therapist, child and family, we expect to see a more child- and family-centred approach to care. On a collective level, the "Kid'EM app" proposal would, as recommended by the WHO, improve professional rehabilitation practices and facilitate convergence towards good clinical practices for professionals (physiotherapists, occupational therapists, PRMs, etc.), thereby increasing the efficiency of the child rehabilitation care system. If its value is demonstrated, the Kid'EM app could be adapted for children with other chronic illnesses requiring non-motor rehabilitation follow-up. The digitization of this goal-setting tool means that this low-cost practice could be widely disseminated.

Conditions

Interventions

TypeNameDescription
OTHERKid'EM app" experimental groupIn the "Kid'EM app" experimental group arm, only the application used differs. Visits are organized in the same way as in the controle app arm. Visit 0 (Inclusion) + Visit 1 (V1) : Physical visit Children are included in the study by the investigator, formalized by signing a consent form. Parents fill in questionnaires Visit 2 (when 1st objective is set): Telephone interview to assess performance and satisfaction levels after the first goal has been set. Visit 3 (when setting the 2nd goal): Telephone interview to assess performance and satisfaction levels after the second goal has been set. Visit 4 (week 14 - end of study): Physical visit The questionnaires are again completed by the parents, either directly on a tablet or on paper for later input. Visit 4 bis: Telephone interview to assess performance and satisfaction levels after the work on the first two objectives. Visit 5 (focus group, optional post-study visit)
OTHERKid'EM app control groupUse of control application without guidance for goal setting Visit 0 (Inclusion) + Visit 1 (V1) : Physical visit Children are included in the study by the investigator, formalized by signing a consent form. Parents fill in questionnaires Visit 2 (when 1st objective is set): Telephone interview to assess performance and satisfaction levels after the first goal has been set. Visit 3 (when setting the 2nd goal): Telephone interview to assess performance and satisfaction levels after the second goal has been set. Visit 4 (week 14 - end of study): Physical visit The questionnaires are again completed by the parents, either directly on a tablet or on paper for later input. Visit 4 bis: Telephone interview to assess performance and satisfaction levels after the work on the first two objectives. Visit 5 (focus group, optional post-study visit)

Timeline

Start date
2025-03-01
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2024-06-26
Last updated
2025-02-05

Locations

36 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06475950. Inclusion in this directory is not an endorsement.